APA (7th ed.) Citation

Agnihotri, S., Mansouri, S., Burrell, K., Li, M., Liu, J., Nejad, R., . . . Vartanian, A. (2018). CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA IN VITRO AND IN VIVO. Neuro-oncology, 20, vi282. https://doi.org/10.1093/neuonc/noy148.1177

Chicago Style (17th ed.) Citation

Agnihotri, Sameer, et al. "CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA IN VITRO AND IN VIVO." Neuro-oncology 20 (2018): vi282. https://doi.org/10.1093/neuonc/noy148.1177.

MLA (9th ed.) Citation

Agnihotri, Sameer, et al. "CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA IN VITRO AND IN VIVO." Neuro-oncology, vol. 20, 2018, p. vi282, https://doi.org/10.1093/neuonc/noy148.1177.